Quigley Jill M. 4
4 · Terns Pharmaceuticals, Inc. · Filed Sep 11, 2024
Insider Transaction Report
Form 4
Quigley Jill M.
Director
Transactions
- Exercise/Conversion
Common Stock
2024-09-09$1.82/sh+17,235$31,368→ 32,235 total - Sale
Common Stock
2024-09-09$10.00/sh−17,235$172,350→ 15,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-09-09−17,235→ 0 totalExercise: $1.82From: 2023-06-12Exp: 2032-06-15→ Common Stock (17,235 underlying)
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2024.
- [F2]The option vested in full immediately prior to the Annual Meeting following the date of grant.